In the fight to end the HIV and AIDS epidemic, a small window of opportunity is opening. Efforts have almost reached the half-way point for ending the disease: the number of those in treatment, 1.7 million people, is on track to surpass the number of new annual infections, about 2 million, by next year. The time is therefore ripe for reassessing what works, what doesn't, and where financing will come from to get and stay ahead of HIV and AIDS.
Devex spoke with Erin Hohlfelder, head of global health policy at the ONE Campaign about the most promising financing tools on the HIV and AIDS front, how the indicators for the Sustainable Development Goals and new financing trends can shape the donor landscape, and how organizations are adapting to the rapidly shifting need to reach the most marginalized populations.
Here are some highlights from that conversation:
About the author
Molly Andersmollyanders_dev
Molly Anders is a former U.K. correspondent for Devex. Based in London, she reports on development finance trends with a focus on British and European institutions. She is especially interested in evidence-based development and women’s economic empowerment, as well as innovative financing for the protection of migrants and refugees. Molly is a former Fulbright Scholar and studied Arabic in Syria, Jordan, Egypt and Morocco.
